Data / Form D filings / Akriveia Therapeutics, LLC
Akriveia Therapeutics, LLC: Form D filings
Akriveia Therapeutics, LLC, a biotechnology company in Skillman, NJ, filed 2 Form D notices with the SEC between 2016 and 2018. The latest, on January 31, 2018, reports $3 million sold of a $22.5 million offering to 1 investor.
Find out what Akriveia Therapeutics, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 23 SOUTHERN HILLS DRIVE, Skillman, NJ, 08558
- Phone
- (609) 560-0927
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1676950
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2018 | New notice | $22,500,000 | $3,000,000 | $19,500,000 | 1 | Jan 23, 2018 | sec.gov |
| Jun 15, 2016 | New notice | $7,500,000 | $4,500,000 | $3,000,000 | 1 | May 25, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Benjamin Auspitz | Director | |
| Thomas Beck | Director | |
| Michael Gladstone | Director | |
| Simon Tomlinson | Executive Officer, Director | |
| David Grayzel | Director |
Other biotechnology companies in New Jersey that filed recently
- Ensho Therapeutics, Inc. $7.3 million · Oct 15, 2026
- Xenon Ophthalmics Inc $3.3 million · Oct 6, 2026
- LISATA THERAPEUTICS, INC. $351.9 million · Oct 2, 2026
Every Form D from the week of Jan 29, 2018 · All recent filings in New Jersey · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Akriveia Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.